Abstract
Human protein S (PS), a cofactor of anti-coagulant-activated protein C (APC), is a modular protein containing 4 epidermal growth factor (EGF)-like domains. EGF1 appears to mediate PS interaction with APC, but the roles of EGFs 2, 3, and 4 are less clear. We synthesized PS variants lacking single EGF domains (EGF2, 3, or 4) and assessed their APC cofactor activity in a factor Va inactivation assay. The variant lacking EGF2 (variant 134) showed the most dramatic loss of activity (∼10% of recombinant wild-type PS activity). Replacement of EGF2 by an additional EGF3 (variant 1334) resulted in a comparable loss of activity, suggesting that the loss of a specific rather than "spacer" function of EGF2 was responsible. We confirmed that the variant 134 had a functional γ-carboxyglutamic acid (Gla) domain and that EGF1 was correctly folded. This is the first clear evidence that EGF2 is required for the expression of PS activity. © 2003 by The American Society of Hematology.
Cite
CITATION STYLE
Mille-Baker, B., Rezende, S. M., Simmonds, R. E., Mason, P. J., Lane, D. A., & Laffan, M. A. (2003). Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity. Blood, 101(4), 1416–1418. https://doi.org/10.1182/blood-2002-08-2353
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.